Showing 2 posts of 2 posts found.
UK pharma has been reassured over the use of risk-sharing schemes with health bodies. The latest revisions to the ABPI …
The ABPI has published the 2011 version of its Code of Practice for UK pharmaceutical companies, with copies now available …
NHS England approves delayed-release treatment for rare kidney disease
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation